Production (Stage)
IRadimed Corporation
IRMD
$57.88
-$0.26-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.93% | 1.93% | 3.03% | 18.49% | -8.88% |
| Total Depreciation and Amortization | -0.41% | -1.37% | -0.75% | -11.94% | 10.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 242.96% | -41.69% | 182.61% | -158.16% | 200.39% |
| Change in Net Operating Assets | -1,078.74% | -93.21% | 28.20% | 220.31% | -50.38% |
| Cash from Operations | -28.31% | -34.32% | 37.32% | 70.95% | -0.75% |
| Capital Expenditure | -32.52% | 26.77% | -235.89% | -319.18% | 49.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.55% | -32.31% | -48.71% | 34.92% | -106.34% |
| Cash from Investing | -28.15% | 23.80% | -215.92% | -165.20% | 24.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 78.56% | -2,947.75% | 72.14% | 0.00% | 85.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.69% | -0.04% | -0.05% | 76.18% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.78% | -26.02% | 2.14% | 75.62% | -2,961.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -471.03% | -83.90% | -6.53% | 173.53% | -253.64% |